Search

Notice Of Verification Of Exclusivity And Uniqueness Of The Supply. Purchase Of N. 1 (One) Illumina Nextseq2000 Sequencing Platform, Based On Sequencing By Synthesis ("Sbs") Technology, For The Research Needs Of The Department Of Medicine And Surgery.

Contract Award

General Information

   Sep 16, 2024
   Italian
   Other
   published: Sep 16, 2024

Original Text

TED















Help Print Share





Share ×

Facebook X/Twitter LinkedIn Email

Cancel





.ted-toolbar {
display: flex;
}

.ted-mini-toolbar {
display: flex;
margin-bottom: 22px;
margin-left: auto;
}

.ted-help,
.ted-download,
.ted-print,
.ted-social-share {
background: none;
border: none;
padding: 0;
}...
Membership Plans

Basic

Full

Corporate

$550/year

$1000/year

Price on request

Buy Buy Contact us

Contract award information

   Illumina Italy S.r.l.
Please note that this notice is for your information only.
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any updates, corrections, or complaints related to this notice, please contact the responsible purchaser directly.